Results 51 to 60 of about 615,695 (310)
An estimated 20% of all patients with cancer will develop brain metastases, with the majority of brain metastases occurring in those with lung, breast and colorectal cancers, melanoma or renal cell carcinoma. Brain metastases are thought to occur via seeding of circulating tumour cells into the brain microvasculature; within this unique ...
Achrol, Achal Singh +10 more
openaire +6 more sources
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source
Diagnostic Accuracy of Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography with Computer Tomography in Detection of Hepatocellular Carcinoma and Its Extrahepatic Metastases [PDF]
Introduction:Hepatocellular carcinoma (HCC) is a global health concern, ranking seventh in cancer incidence and third in cancer-related mortality. Extrahepatic metastases occur in 37% of cases, with common sites being the lung, lymph nodes, and bone ...
Ahmed Bessar +3 more
doaj +1 more source
Objectives: This study aimed to compare the short and long-term outcomes of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer
Shinya Yoshida +7 more
doaj +1 more source
Skin metastases: three-year study of 50 cases in a university center [PDF]
Introduction. Skin metastases are rare metastases of internal or cutaneous tumors, commonly diagnosed after the primary cancer. Sometimes, they can be the first manifestation of a malignancy.
Oana M. PATRASCU +6 more
core +2 more sources
A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma
Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos +9 more
wiley +1 more source
Prognostic significance of thrombocytosis in metastatic colorectal cancer
Objective: Thrombocytosis was frequently observed in patients with malignancies and was associated with reduced overall survival and poor prognosis. The aim of this study was to evaluate the prognostic impact of thrombocytosis on patient survival up to ...
Matea Rebrina +5 more
doaj +1 more source
Sclerosing epithelioid fibrosarcoma: rare and serious
Sclerosing Epithelioid Fibrosarcoma (SEF) is a rare form of soft tissue sarcoma. It is characterized by a slow evolution, with local recurrences and late metastases that are mainly pulmonary and pleural in about 50% of cases.
Mounir Yahyaoui +6 more
doaj +1 more source
To identify the advantageous therapy as the first-line treatment for patients with triple-negative breast cancer (TNBC). Randomized controlled trials were searched for on Medline, Embase, ClinicalTrials.gov, and the Cochrane Library between January 2001 ...
Yiqun Han +5 more
doaj +1 more source
Metastatic niche shaped by host factors influences disseminated cancer cell fate
Metastasis is shaped not only by cancer cells but also by the environments they encounter. This review explores how factors such as aging, diet, the microbiome, lifestyle, and environmental exposures remodel organ‐specific niches in the lung, liver, bone, and brain, influencing where metastatic cells survive, remain dormant, or grow, and ultimately ...
Gwennan Delyth Ward +2 more
wiley +1 more source

